Showing results (821-830 of 871) with videos related to

Sort By:
Pageof 88
Cells|February 12, 2026
Dendrimer-Conjugated Glutamine Antagonist, D-TTM020, Ameliorates Brain Immune Dysregulation and Improves Neurobehavioral Deficits in the <i>Mecp2-</i>Deficient Mouse ModelPreeti Vyas, Elizabeth Smith Khoury, Nirnath Sah, et al.
The Lancet. Oncology|August 14, 2025
Health-related quality of life in patients with KRAS<sup>G12C</sup>-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trialDominik Paul Modest, Marwan Fakih, Lisa Salvatore, et al.
Physics in Medicine and Biology|November 17, 2020
Out-of-field doses for scanning proton radiotherapy of shallowly located paediatric tumours-a comparison of range shifter and 3D printed compensatorA Wochnik, L Stolarczyk, I Ambrožová, et al.
Journal of Medicinal Chemistry|August 1, 2017
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive DisordersMichael T Nedelcovych, Lukáš Tenora, Boe-Hyun Kim, et al.
Scientific Reports|April 15, 2023
The response to stressors in adulthood depends on the interaction between prenatal exposure to glucocorticoids and environmental contextAriana D Majer, Ryan T Paitz, Gianna M Tricola, et al.
Journal of Medicinal Chemistry|May 2, 2003
Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitorPavel Majer, Paul F Jackson, Greg Delahanty, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666Kenneth W Duncan, Nathalie Rioux, P Ann Boriack-Sjodin, et al.
Chembiochem : a European Journal of Chemical Biology|April 10, 2021
Targeted Degradation of PARP14 Using a Heterobifunctional Small MoleculeTim J Wigle, Yue Ren, Jennifer R Molina, et al.
Science Advances|November 16, 2022
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrugRana Rais, Kathryn M Lemberg, Lukáš Tenora, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Gastric epithelium from <i>BRCA1</i> and <i>BRCA2</i> carriers harbors increased double-stranded DNA damage and augmented growthKole H Buckley, Michaela E Dungan, Kevin Dinh, et al.
Pageof 88